Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Watchlist
Price: 65.66 USD 1.02% Market Closed
Market Cap: 12.5B USD
Have any thoughts about
Biomarin Pharmaceutical Inc?
Write Note

Intrinsic Value

The intrinsic value of one BMRN stock under the Base Case scenario is 71.11 USD. Compared to the current market price of 65.66 USD, Biomarin Pharmaceutical Inc is Undervalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BMRN Intrinsic Value
71.11 USD
Undervaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Biomarin Pharmaceutical Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for BMRN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about BMRN?
Bearish
Neutral
Bullish

Fundamental Analysis

65.66 USD
+1.02%
+1.02%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Biomarin Pharmaceutical Inc
US
Biotechnology
Market Cap
12.5B USD
IPO
Jul 23, 1999
Employees
3 045
United States of America
Market Cap
12.5B USD
Industry
Biotechnology
IPO
Jul 23, 1999
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Biomarin Pharmaceutical Inc

Provide an overview of the primary business activities
of Biomarin Pharmaceutical Inc.

What unique competitive advantages
does Biomarin Pharmaceutical Inc hold over its rivals?

What risks and challenges
does Biomarin Pharmaceutical Inc face in the near future?

Has there been any significant insider trading activity
in Biomarin Pharmaceutical Inc recently?

Summarize the latest earnings call
of Biomarin Pharmaceutical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biomarin Pharmaceutical Inc.

Provide P/S
for Biomarin Pharmaceutical Inc.

Provide P/E
for Biomarin Pharmaceutical Inc.

Provide P/OCF
for Biomarin Pharmaceutical Inc.

Provide P/FCFE
for Biomarin Pharmaceutical Inc.

Provide P/B
for Biomarin Pharmaceutical Inc.

Provide EV/S
for Biomarin Pharmaceutical Inc.

Provide EV/GP
for Biomarin Pharmaceutical Inc.

Provide EV/EBITDA
for Biomarin Pharmaceutical Inc.

Provide EV/EBIT
for Biomarin Pharmaceutical Inc.

Provide EV/OCF
for Biomarin Pharmaceutical Inc.

Provide EV/FCFF
for Biomarin Pharmaceutical Inc.

Provide EV/IC
for Biomarin Pharmaceutical Inc.

Show me price targets
for Biomarin Pharmaceutical Inc made by professional analysts.

What are the Revenue projections
for Biomarin Pharmaceutical Inc?

How accurate were the past Revenue estimates
for Biomarin Pharmaceutical Inc?

What are the Net Income projections
for Biomarin Pharmaceutical Inc?

How accurate were the past Net Income estimates
for Biomarin Pharmaceutical Inc?

What are the EPS projections
for Biomarin Pharmaceutical Inc?

How accurate were the past EPS estimates
for Biomarin Pharmaceutical Inc?

What are the EBIT projections
for Biomarin Pharmaceutical Inc?

How accurate were the past EBIT estimates
for Biomarin Pharmaceutical Inc?

Compare the revenue forecasts
for Biomarin Pharmaceutical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biomarin Pharmaceutical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biomarin Pharmaceutical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biomarin Pharmaceutical Inc compared to its peers.

Compare the P/E ratios
of Biomarin Pharmaceutical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Biomarin Pharmaceutical Inc with its peers.

Analyze the financial leverage
of Biomarin Pharmaceutical Inc compared to its main competitors.

Show all profitability ratios
for Biomarin Pharmaceutical Inc.

Provide ROE
for Biomarin Pharmaceutical Inc.

Provide ROA
for Biomarin Pharmaceutical Inc.

Provide ROIC
for Biomarin Pharmaceutical Inc.

Provide ROCE
for Biomarin Pharmaceutical Inc.

Provide Gross Margin
for Biomarin Pharmaceutical Inc.

Provide Operating Margin
for Biomarin Pharmaceutical Inc.

Provide Net Margin
for Biomarin Pharmaceutical Inc.

Provide FCF Margin
for Biomarin Pharmaceutical Inc.

Show all solvency ratios
for Biomarin Pharmaceutical Inc.

Provide D/E Ratio
for Biomarin Pharmaceutical Inc.

Provide D/A Ratio
for Biomarin Pharmaceutical Inc.

Provide Interest Coverage Ratio
for Biomarin Pharmaceutical Inc.

Provide Altman Z-Score Ratio
for Biomarin Pharmaceutical Inc.

Provide Quick Ratio
for Biomarin Pharmaceutical Inc.

Provide Current Ratio
for Biomarin Pharmaceutical Inc.

Provide Cash Ratio
for Biomarin Pharmaceutical Inc.

What is the historical Revenue growth
over the last 5 years for Biomarin Pharmaceutical Inc?

What is the historical Net Income growth
over the last 5 years for Biomarin Pharmaceutical Inc?

What is the current Free Cash Flow
of Biomarin Pharmaceutical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biomarin Pharmaceutical Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biomarin Pharmaceutical Inc

Current Assets 3.1B
Cash & Short-Term Investments 930.4m
Receivables 777.5m
Other Current Assets 1.3B
Non-Current Assets 3.8B
Long-Term Investments 568.8m
PP&E 1B
Intangibles 457.1m
Other Non-Current Assets 1.7B
Current Liabilities 715.7m
Accounts Payable 312.3m
Accrued Liabilities 378.6m
Other Current Liabilities 24.7m
Non-Current Liabilities 722.1m
Long-Term Debt 594.6m
Other Non-Current Liabilities 127.5m
Efficiency

Earnings Waterfall
Biomarin Pharmaceutical Inc

Revenue
2.8B USD
Cost of Revenue
-579.6m USD
Gross Profit
2.2B USD
Operating Expenses
-1.8B USD
Operating Income
409.6m USD
Other Expenses
-87.3m USD
Net Income
322.3m USD

Free Cash Flow Analysis
Biomarin Pharmaceutical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BMRN Profitability Score
Profitability Due Diligence

Biomarin Pharmaceutical Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
ROIC is Increasing
52/100
Profitability
Score

Biomarin Pharmaceutical Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

BMRN Solvency Score
Solvency Due Diligence

Biomarin Pharmaceutical Inc's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
94/100
Solvency
Score

Biomarin Pharmaceutical Inc's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BMRN Price Targets Summary
Biomarin Pharmaceutical Inc

Wall Street analysts forecast BMRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BMRN is 98.93 USD with a low forecast of 65.65 USD and a high forecast of 133.35 USD.

Lowest
Price Target
65.65 USD
0% Downside
Average
Price Target
98.93 USD
51% Upside
Highest
Price Target
133.35 USD
103% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BMRN?

Click here to dive deeper.

Dividends

Biomarin Pharmaceutical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BMRN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BMRN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

BMRN News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one BMRN stock?

The intrinsic value of one BMRN stock under the Base Case scenario is 71.11 USD.

Is BMRN stock undervalued or overvalued?

Compared to the current market price of 65.66 USD, Biomarin Pharmaceutical Inc is Undervalued by 8%.

Back to Top